MA11.09 Phase II Trial of Atezolizumab Plus Cobimetinib in PD-(L)1 Inhibitor Resistant NSCLC: NCI ETCTN Study 10166
Year: 2024
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: A. Saltos, R. Hall, M. Tan, C. Kim, A. Saxena, K. He, H. Mamdani, T.W. Lycan, L. Villaruz, M. Khalil, R. Aljumaily, T. Tanvetyanon, R.D. Gentzler, B. Ma, D. Ozisik, J.A. Murray, S.V. Liu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4403410337